You may be offered the opportunity to take part in a clinical trial at some point during your treatment. Clinical trials are research studies that evaluate the safety and effectiveness of new treatment approaches for diseases. In some cases, a study may give you access to new therapies that are not yet readily available. Clinical trials may also be used to compare diagnostic tests, prevention strategies, or other aspects of care for cancer patients. Learn more about clinical trials.
Below is a listing of breast cancer clinical trials that are currently enrolling patients at Memorial Sloan-Kettering Cancer Center.
| Title |
Investigator |
|---|---|
|
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults [Protocol 12-089] |
Tew, William, MD |
|
A Phase II Study of Abiraterone, Exemestane, or Both in Postmenopausal Women with ER-Positive Metastatic Breast Cancer [Protocol 12-140] |
Traina, Tiffany, MD |
|
A Phase I Study of Enzalutamide (MDV3100) in Patients with Previously Treated Metastatic Breast Cancer [Protocol 12-155] |
Traina, Tiffany, MD |
|
A Phase II Study of Abraxane with or without Tigatuzumab in Patients with Metastatic Triple-Negative Breast Cancer [Protocol 11-082] |
Traina, Tiffany, MD |
|
A Phase II Study of Dose-Dense Doxorubicin and Cyclophosphamide followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer [Protocol 10-190] |
Traina, Tiffany, MD |
|
Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmetic Appearance in Patients with Multiple Tumors in One Breast [Protocol 13-023] |
Van Zee, Kimberly, MD |
Related Topics
Recommended Links
